VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > .50 warrants expire on Friday

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon May 17, 2021 1:56pm

190 Views

Post# 33215010

RE:RE:.50 warrants expire on Friday

GrahamB wrote:

chry200030 wrote:
Blue sky afterwards.

Are you suggesting the .50 warrants are holding down the stock price?

Where the market price is below the strike price -that doesn't seem to be probable.

It seems to me when warrants are exercised it brings cash into the company coffers but it also dilutes the O/S share count by adding that many more shares. Don't really understand the pros and cons of each -- and therefore also don't understand why it would influence the big traders to depress the share price.

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week